Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
Status:
Completed
Trial end date:
2020-01-03
Target enrollment:
Participant gender:
Summary
This study looks at a new study medicine for weight management in people with overweight or
obesity. The aim of this study is to find out how safe and tolerable the study medicine is.
The study also looks at how the study medicine behaves in the body and how it is removed from
the body.
Participants will either get NNC9204-1177 (the new study medicine) or placebo (a formula that
looks like the study medicine but does not have active ingredients). Which treatment
participants get will be decided by chance.
NNC9204-1177 has not been approved by the United States Food and Drug Administration. Its use
in this study is experimental. Participants will get 1 or more injections into the skin of
the stomach area once each week for 12 weeks.
The study will last for about 5 months. Participants will have 19 clinic visits with the
study doctor. At certain times during the study, participants will have blood draws and 3
different kinds of electrocardiograms. Participants will answer mental health questionnaires.
Women: Women cannot take part if pregnant, breast-feeding or plan to become pregnant during
the study period.